Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Robins Harlan S sold 492,400 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Jul 21, 2026 · Filed Jul 23, 2026
On Jul 21, 2026, Robins Harlan S (Chief Scientific Officer) sold 492,400 Adaptive Biotechnologies Corporation shares at an average US$21.89 for US$10.8M under a trading plan, leaving 812,058 shares. Filed Jul 23, 2026 (Form 4).
- Sold
- 492,400 shares
- Price
- US$21.89 average (US$21.72 to US$22.12)
- Value
- US$10.8M
- Holding after
- 812,058 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Common Stock | Option exercise | 284,800 | US$6.55 | 1,304,458 | Direct |
| Jul 21, 2026 | Common Stock | Sale | 278,698 | US$21.72 | 1,025,760 | Direct |
| Jul 21, 2026 | Common Stock | Sale | 213,702 | US$22.12 | 812,058 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Robins Harlan S
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Robins Harlan S · Jul 7, 2026
- Form 4 · Robins Harlan S · Jun 17, 2026
- Form 4 · Robins Harlan S · Apr 10, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026